Dynavax Technologies
DVAX
#5484
Rank
ยฃ0.96 B
Marketcap
ยฃ8.22
Share price
0.05%
Change (1 day)
-18.96%
Change (1 year)

Dynavax Technologies (DVAX) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.48 Billion

According to Dynavax Technologies 's latest financial reports the company has ยฃ0.48 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dynavax Technologies - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.56 B-2.37%
2023-12-31ยฃ0.58 B12.89%
2022-12-31ยฃ0.51 B27.61%
2021-12-31ยฃ0.40 B234.05%
2020-12-31ยฃ0.12 B5.11%
2019-12-31ยฃ0.11 B0.47%
2018-12-31ยฃ0.11 B-19.23%
2017-12-31ยฃ0.14 B115.14%
2016-12-31ยฃ65.98 M-50.14%
2015-12-31ยฃ0.13 B67.99%
2014-12-31ยฃ78.77 M-31.38%
2013-12-31ยฃ0.11 B48.3%
2012-12-31ยฃ77.41 M5.59%
2011-12-31ยฃ73.32 M56.87%
2010-12-31ยฃ46.74 M105.98%
2009-12-31ยฃ22.69 M-51.43%
2008-12-31ยฃ46.72 M5.18%
2007-12-31ยฃ44.42 M19.47%
2006-12-31ยฃ37.18 M-14.63%
2005-12-31ยฃ43.55 M26.99%
2004-12-31ยฃ34.29 M110.85%
2003-12-31ยฃ16.26 M-11.32%
2002-12-31ยฃ18.34 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Agenus
AGEN
ยฃ2.59 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ2.97 B 511.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ13.66 B 2,711.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ5.51 B 1,034.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ6.13 B 1,163.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
ยฃ3.33 B 586.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ11.23 B 2,213.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.65 B 240.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
ยฃ7.08 B 1,357.98%๐Ÿ‡บ๐Ÿ‡ธ USA